巨星医疗控股(02393.HK)中期纯利增长20.06%至1.42亿元
格隆汇8月15日丨巨星医疗控股(02393.HK)公布,截至2019年6月30日止六个月,实现收益22.87亿元人民币(单位下同),同比增长12%;毛利6.41亿元,同比增长13.48%;归属于母公司拥有人期内溢利1.42亿元,同比增长20.06%;基本及摊薄每股盈利5.91分;不派息。
公告称,截至2019年6月30日,集团已与1,508间医院及诊所建立直销及服务关系,与去年同期的1,377间医院及诊所比较增长约9.5%。
据悉,医疗业务占总体收益89.7%。集团有关分部收益为20.52亿元,按年增长18.6%。分部毛利率与去年同期的30.0%比较保持相对稳定,约为29.3%。此外,非医疗业务占总体收益10.3%。于本期间,集团非医疗业务的收益为2.348亿元,按年减少约24.6%。分部毛利率为16.7%,上升2.2个百分点。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.